Aberrant Expression of CXCR4 Significantly Contributes to Metastasis and Predicts Poor Clinical Outcome in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|14|1|174-184

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.14, Iss.1, 2014-01, pp. : 174-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 410-416

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome

By Surowiak Paweł   Materna Verena   Maciejczyk Adam   Pudełko Marek   Markwitz Ewa   Spaczyński Marek   Dietel Manfred   Zabel Maciej   Lage Hermann  

Virchows Archiv, Vol. 450, Iss. 3, 2007-03 ,pp. : 279-285

Springer Publishing Company

Access to resources Recommend Favorite

Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation

By  

Current Molecular Medicine, Vol. 13, Iss. 10, 2013-12 ,pp. : 1538-1548

Bentham Science Publishers

Access to resources Recommend Favorite

Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

By Brosens R.  

Cellular Oncology, Vol. 34, Iss. 3, 2011-06 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 6, 2013-01 ,pp. : 1031-1038

Spandidos Publications

Access to resources Recommend Favorite